Manifold Biotechnologies, Inc. develops biotechnology solutions for biologic drug discovery and development, specializing in molecular tracking and high-throughput in vivo screening. The company builds an AI-guided direct-to-vivo discovery platform designed to accelerate the development of tissue-targeted medicines, including RNA interference treatments for neurological diseases.
Subscribe to see Manifold Biotechnologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Manifold Biotechnologies, Inc. is a biotech company headquartered in United States. Its most recent funding round raised $32.8M in November 2024. Xcout tracks 16 named people at Manifold Biotechnologies, Inc., including Gleb Kuznetsov (Chief Executive Officer). Xcout recorded 7 job postings from Manifold Biotechnologies, Inc. in the last 90 days.
10 more named people on record for Manifold Biotechnologies, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $32.8M | — | |
| — | $40M | 5 named | |
| SEC Form D filing | $5.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 7 job postings from Manifold Biotechnologies, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Manifold Biotechnologies, Inc.'s hiring signals →
A few of Manifold Biotechnologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
Nosis Biosciences develops receptor-targeted RNA medicines utilizing its proprietary AI-powered platform, Connexa, which combines physics-aware deep learning, single cell biology, and high-throughput chemistry. The company's platform designs gene-silencing therapeutics intended to treat chronic conditions across various cell types and organ systems, including the heart, lungs, kidneys, and brain.
Herophilus is a neurotherapeutics discovery company headquartered in San Francisco, California. The company utilizes artificial intelligence, human stem cell models, and phenotypic screening platforms to discover and develop new drugs for neurodegenerative and neurological diseases.
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Matchpoint Therapeutics is a privately held biotechnology company based in Watertown, Massachusetts, focused on advancing a pipeline of first-in-class oral small molecules for autoimmune and inflammatory diseases.
Octant Bio is a biotechnology company that combines next-generation biology, chemistry, and computation to discover and develop precision small molecule therapeutics. The company targets complex cellular mechanisms to address genetic diseases, such as protein misfolding and mistrafficking across various therapeutic areas including genetic disorders, oncology, metabolism, and immunology.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Manifold Biotechnologies, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.